For Black Americans, the battle with Chronic Myeloid Leukemia is marked by unique survival challenges and treatment ...
The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...
In The Lancet Hematology, Jorge E Cortes and colleagues1 report a phase 1/2 study on vodobatinib in patients with resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback